Sunil Bhavsar - Concepedia

Author

Sunil Bhavsar

Amplyx Pharmaceuticals (United States)ORCID

Also Known As

S BHAVSAR, S Bhavsar, S P Bhavsar, S. Bhavsar, SUNIL BHAVSAR, Sunil Bhavsar, Swati Bhavsar

Publications

1.2K

Citations

H-Index

Concepts

All Affiliations

Amplyx Pharmaceuticals (United States)MannKind Corporation (United States)

About

Sunil Bhavsar is an author at Amplyx Pharmaceuticals (United States) specializing in pharmacology, medicine, and physiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	471
2	Health Sciences	3	3	383
3	Diabetes	2	2	245
4	Endocrinology	2	2	357
5	Public Health	1	1	124

Sunil Bhavsar

Publications

1.1K

Citations

H-Index

Page 1

	Year	Citations
Glucose-lowering and insulin-sensitizing actions of exendin-4: studies in obese diabetic (ob/ob, db/db) mice, diabetic fatty Zucker rats, and diabetic rhesus monkeys (Macaca mulatta). Andrew A. Young, Bronislava Gedulin, Sunil Bhavsar, Diabetes	1999	442
Effects of PYY[3–36] in rodent models of diabetes and obesity Richard Pittner, Candace X. Moore, Sunil Bhavsar, International Journal of Obesity ObesityCaloric RestrictionMetabolic SyndromeEnergy HomeostasisMetabolic Disorder	2004	219
Antiobesity action of peripheral exenatide (exendin-4) in rodents: effects on food intake, body weight, metabolic status and side-effect measures Christine M. Mack, Candace X. Moore, Carolyn M. Jodka, International Journal of Obesity ObesityMetabolic SyndromeNutritionMedicinePhysiology	2006	138
Synergy between amylin and cholecystokinin for inhibition of food intake in mice Sunil Bhavsar, Justin Watkins, Andrew W. Young Physiology & Behavior NutritionAppetite ControlFood DigestionPhysiologyFood Intake	1998	124
Pharmacokinetics and pharmacodynamics of exenatide following alternate routes of administration Bronislava Gedulin, Pam Smith, Carolyn M. Jodka, International Journal of Pharmaceutics Alternate RoutesPharmacological StudyPharmacodynamicsExcipientsMedicine	2008	88
Prophylactic use of anti‐emetic medications reduced nausea and vomiting associated with exenatide treatment: a retrospective analysis of an open‐label, parallel‐group, single‐dose study in healthy subjects C. Ellero, J. Han, Sunil Bhavsar, Diabetic Medicine	2010	33
Evolution of Exenatide as a Diabetes Therapeutic Sunil Bhavsar, Sunder Mudaliar, Alan D. Cherrington Current Diabetes Reviews Metabolic SyndromeEffective Diabetes TherapyDiabetes ManagementMedicineInsulin Management	2013	26
Reduction in Postprandial Peak Glucose With Increased Technosphere Insulin Dosage Kevin B. Kaiserman, Mark P. Christiansen, Sunil Bhavsar, Journal of Diabetes Science and Technology	2022	18
Time–Action Profile of Technosphere Insulin in Children with Type 1 Diabetes Michael J. Haller, Marisa Jones, Sunil Bhavsar, Diabetes Therapy	2023	13

Page 1